Insights into Changes to the Priority Review System from the Perspective of the New Provisions for Drug Registration in China

WANG Jing-can, WEN Bao-shu, PU Jia-qi

Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (24) : 2074-2077.

PDF(1203 KB)
PDF(1203 KB)
Chinese Pharmaceutical Journal ›› 2020, Vol. 55 ›› Issue (24) : 2074-2077. DOI: 10.11669/cpj.2020.24.013

Insights into Changes to the Priority Review System from the Perspective of the New Provisions for Drug Registration in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 55(24): 2074-2077 https://doi.org/10.11669/cpj.2020.24.013

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1203 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉